5:00 pm - 6:00 pm MDT
4:00 pm - 5:00 pm PDT
LEARNING OBJECTIVES
After completing this learning activity, participants will be better able to:
- Discuss factors one must consider in choosing available Canadian first-line treatments and options for subsequent therapies for presented patient cases diagnosed with mRCC
- Review Canadian mRCC treatment algorithms and patient adverse event management strategies
Medical Oncologist, Juravinski Cancer Centre
After residency training, Dr. Lalani was awarded the TD Insurance Meloche Monnex & Alberta Medical Association Scholarship. He pursued a Fellowship in Genitourinary Oncology at Dana-Farber Cancer Institute in Boston, mentored by Dr. Toni Choueiri. He has also completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. He is a member of the Escarpment Cancer Research Institute. His academic interests include clinical trial design and translational work for genitourinary malignancies. He is the lead PI for the CYTOSHRINK clinical trial.
Centre Hospitalier de l’Université de Montréal (CHUM)
Dr. Blais received an MD from Sherbrooke University in 1990, followed by a residency in Internal Medicine, Hematology and Medical Oncology in Sherbrooke and Montreal. He received a MSc from McMaster University in 2005.
His interests and expertise include clinical trials and correlative science, specifically in lung and bladder cancer, as well as clinical and research interests in cancer associated thrombosis. Dr. Blais is a Co-founder of the Groupe d’Études en Oncologie du Québec (www.geoq.com) and Chair of the CHUM Cancer Center thoracic oncology program.
Assistant Professor, University of Toronto
Dr. Shaan Dudani is a medical oncologist at the William Osler Health System with an interest in genitourinary and gastrointestinal malignancies. He went to medical school at the University of Birmingham in the United Kingdom followed by Internal Medicine and Medical Oncology residencies at the University of Ottawa. He subsequently completed a clinical research fellowship in genitourinary oncology with a focus on kidney cancer at the Tom Baker Cancer Centre and University of Calgary as well as a Master’s in Public Health from Harvard University.